EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Selective Use of Nonselective Beta-Blockers

Davide Genovese, Giuseppe Sgarito, Donatella Ruggiero, Laura Perrotta, Pietro Francia, Francesco Santoro, Giacomo Mugnai

JACC: Clinical Electrophysiology · 2026-07 · 12 (7) · 1745-1759

DOI: 10.1016/j.jacep.2026.05.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JACC: Clinical Electrophysiology, 2026-07. Verfasst von Davide Genovese und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Unit, Cardio-Neuro-Vascular Department, Ca' Foncello Hospital, Treviso, Italy. Electronic address: genovesedavide@outlook.com. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Anti-Arrhythmia Agents, Arrhythmias, Cardiac. Die Arbeit nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beta-blockers (BBs) are a cornerstone of antiarrhythmic therapy, yet assuming a uniform "class effect" oversimplifies their diverse pharmacological properties and might compromise efficacy. This review synthesizes evidence comparing the antiarrhythmic effects of different BBs in various clinical settings. While cardioselective agents offer improved tolerability, they often fail to blunt the broad adrenergic surge driving specific arrhythmias. Nonselective BBs (eg, nadolol, propranolol) provide superior efficacy in inherited channelopathies, such as catecholaminergic polymorphic ventricular tachycardia and long QT syndrome, and life-threatening electrical storms. Furthermore, carvedilol is superior to metoprolol for preventing postoperative atrial fibrillation and reducing inappropriate shocks in patients with implantable cardioverter-defibrillators. Conversely, for managing chronic supraventricular tachycardia, cardioselective agents remain preferred. By leveraging distinct BB properties, clinicians can overcome the "one-size-fits-all" approach and tailor therapy to optimize antiarrhythmic efficacy. More research is needed to resolve uncertainties and assist clinicians in adopting a personalized approach to BBs therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenergic beta-AntagonistsAnti-Arrhythmia AgentsArrhythmias, CardiacHumansAtrial Fibrillation

Stichwörter der Autor:innen

antiarrhythmic drugsatrial fibrillationbeta-blockerschannelopathieselectrical stormpersonalized medicineventricular arrhythmias

Substanzen

Adrenergic beta-AntagonistsAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Cardiology Unit, Cardio-Neuro-Vascular Department, Ca' Foncello Hospital, Treviso, Italy. Electronic address: genovesedavide@outlook.com.
  • Istituto di Ricovero e Cura a Carattere Scientifico Istituto Mediterraneo Trapianto e Terapia ad alta Specializzazione, UPMC Palermo, Palermo, Italy.
  • Ospedale Pio XI, Desio, Italy.
  • Arrhythmia Unit, Department of Cardiology, Careggi University Hospital, Florence, Italy.
  • Cardiology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, University Sapienza, Rome, Italy.
  • Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.

Zitieren

APA

Genovese, D., Sgarito, G., Ruggiero, D., Perrotta, L., Francia, P., Santoro, F., & Mugnai, G. (2026). Selective Use of Nonselective Beta-Blockers. JACC: Clinical Electrophysiology, 12(7), 1745-1759. https://doi.org/10.1016/j.jacep.2026.05.002

Vancouver

Genovese D, Sgarito G, Ruggiero D, Perrotta L, Francia P, Santoro F, et al. Selective Use of Nonselective Beta-Blockers. JACC: Clinical Electrophysiology. 2026;12(7):1745-1759. doi:10.1016/j.jacep.2026.05.002

BibTeX
@article{Genovese2026,
  author = {Genovese, Davide and Sgarito, Giuseppe and Ruggiero, Donatella and Perrotta, Laura and Francia, Pietro and Santoro, Francesco and Mugnai, Giacomo},
  title = {Selective Use of Nonselective Beta-Blockers},
  journal = {JACC: Clinical Electrophysiology},
  year = {2026},
  volume = {12},
  number = {7},
  pages = {1745--1759},
  doi = {10.1016/j.jacep.2026.05.002}
}
Kostenlos starten →